 ThirdAge | Unique Cell in Multiple Sclerosis ThirdAge Clinical trials have shown daclizumab appears to help quiet the autoimmune response in MS patients, but its precise effects on the legions of cells that make up the immune system are not fully understood, Beilokova said. The study, published in Science ... |
